chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia, Taste disorder
Clinical narrative: Things tasted a little funny but I mostly noticed it with coffee; Exactly two weeks after the first vaccine I started smelling cigarette smoke and a sweet garlicky smell; This is a spontaneous report from a contactable healthcare professional (patient). This 37-year-old female patient received dose 1 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number EJ1685) via an unspecified route of administration on 07Jan2021 at 09:30 (at the age of 37-years-old) as a single dose in the left arm for COVID-19 immunization. The patient had no medical history. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Prior to the vaccine, the patient was not diagnosed with COVID-19. Concomitant medications included a multivitamin and an estrogen supplement. The patient previously received sulfa and clindamycin from unknown dates for unknown indications and experienced allergy. Exactly two weeks after the first vaccine on 21Jan2021 the patient experienced smelling cigarette smoke and a sweet garlicky smell. Things tasted a little bit funny but she mostly noticed it with coffee. She thought maybe she had a cold. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events.The outcome of smelling cigarette smoke and a sweet garlicky smell were not recovered. It was also reported that since the vaccine the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Confusional state, Fatigue
Clinical narrative: fever 99.9/ fever 100.6; chills; sweats; muscle aches; joint aches; fatigue; confusion; migraine; severe nausea; This is a spontaneous report from a non-contactable consumer (patient). This 29-year-old female patient received dose 1 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number EN6201) via an unspecified route of administration on 15Feb2021 at 13:00 (at the age of 29-years old) as a single dose in the left arm for COVID-19 immunization. Medical history included asthma. The patient was not pregnant at the time of vaccination. The patient had not received any other vaccines within 4 weeks prior to the vaccine. It was unknown if the patient was diagnosed with COVID-19 prior to the vaccine. Concomitant medications included birth control; caffeine, paracetamol (EXCEDRIN), and ibuprofen from unknown dates for unknown indications. The patient previously received acetaminophen in doses over 500 mg and experienced allergy. On 16Feb2021 at 02:00, 13 hours after the vaccine, the patient experienced fever of 99.9, chills, and sweats. Sixteen to twenty-eight hours after the vaccine the patient experienced fever of 100.6, sweats, muscle aches, joint aches, fatigue, confusion, migraine, and severe nausea. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of fevers of 99.9 and 100.6, chills, sweats, muscle aches, joint aches, fatigue, confusion, migraine, and severe nausea were recovered. It was also reported that since the vaccine, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Migraine, Myalgia, Nausea, Pyrexia
Clinical narrative: fever 99.9/ fever 100.6; chills; sweats; muscle aches; joint aches; fatigue; confusion; migraine; severe nausea; This is a spontaneous report from a non-contactable consumer (patient). This 29-year-old female patient received dose 1 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number EN6201) via an unspecified route of administration on 15Feb2021 at 13:00 (at the age of 29-years old) as a single dose in the left arm for COVID-19 immunization. Medical history included asthma. The patient was not pregnant at the time of vaccination. The patient had not received any other vaccines within 4 weeks prior to the vaccine. It was unknown if the patient was diagnosed with COVID-19 prior to the vaccine. Concomitant medications included birth control; caffeine, paracetamol (EXCEDRIN), and ibuprofen from unknown dates for unknown indications. The patient previously received acetaminophen in doses over 500 mg and experienced allergy. On 16Feb2021 at 02:00, 13 hours after the vaccine, the patient experienced fever of 99.9, chills, and sweats. Sixteen to twenty-eight hours after the vaccine the patient experienced fever of 100.6, sweats, muscle aches, joint aches, fatigue, confusion, migraine, and severe nausea. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of fevers of 99.9 and 100.6, chills, sweats, muscle aches, joint aches, fatigue, confusion, migraine, and severe nausea were recovered. It was also reported that since the vaccine, the patient had not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain
Clinical narrative: Headache; Muscle and body aches; Muscle and body aches; This is a spontaneous report received from contactable consumer, the patient. A 62-year-old adult male received the second dose of BNT162b2 (solution for injection; Lot EL3247expiry not provided) as a single dose via unspecified route in the left arm on 19Feb2021 at 12:00 (at 62-years-old) for COVID-19 immunisation. The patient reported no medical history and denied any allergies to medications, foods or other products. There were no concomitant medications reported. The patient previously received COVID-19 immunisation with the first dose of BNT162b2 (lot EL3247) in the left arm on 29Jan2021 at 12:30 (at 62-years-old). The patient denied receiving any other vaccination within four weeks prior to the COVID vaccine. The patient also denied being diagnosed with COVID prior to the vaccination. On 21Feb2021 at 08:00 the patient began to experience headache and muscle and body aches. The patient denied being tested for COVID since being vaccinated. There was no treatment received. The outcome of the events, headache and muscle and body aches was recovered on an unspecified date in Feb2021.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Pain, Rash
Clinical narrative: Body aches; fatigue; chills; headache; rash on hands and arms; shaking; soreness at injection site; This is a spontaneous report from a contactable healthcare professional (patient). This 42-year-old female patient received dose 2 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number EN5318) via an unspecified route of administration on 11Feb2021 at 11:00 (at the age of 42-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. The patient did not take any concomitant medications. The patient previously received acetaminophen, propoxyphene (DARVOCET), cephalexin, and pineapple and experienced allergy. The patient previously received dose 1 of BNT162B2 (lot number EL3249) on 21Jan2021 at 11:00 as a single dose in the left arm for COVID-19 immunization. After dose 2 of BNT162B2, on 12Feb2021 at 04:00 the patient experienced body aches, fatigue, chills, headache, rash on hands and arms, shaking, and soreness at injection site. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of body aches, fatigue, chills, headache, rash on hands and arms, shaking, and soreness at injection site were recovered. It was also reported that since the vaccine the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor, Vaccination site pain
Clinical narrative: Body aches; fatigue; chills; headache; rash on hands and arms; shaking; soreness at injection site; This is a spontaneous report from a contactable healthcare professional (patient). This 42-year-old female patient received dose 2 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE; lot number EN5318) via an unspecified route of administration on 11Feb2021 at 11:00 (at the age of 42-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history was none. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. The patient did not take any concomitant medications. The patient previously received acetaminophen, propoxyphene (DARVOCET), cephalexin, and pineapple and experienced allergy. The patient previously received dose 1 of BNT162B2 (lot number EL3249) on 21Jan2021 at 11:00 as a single dose in the left arm for COVID-19 immunization. After dose 2 of BNT162B2, on 12Feb2021 at 04:00 the patient experienced body aches, fatigue, chills, headache, rash on hands and arms, shaking, and soreness at injection site. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of body aches, fatigue, chills, headache, rash on hands and arms, shaking, and soreness at injection site were recovered. It was also reported that since the vaccine the patient had not been tested for COVID-19.  No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Headache, Lip pain, Malaise, Oral herpes
Clinical narrative: moderately painful herpes simplex virus blister on my lower lip; moderately painful herpes simplex virus blister on my lower lip; felt mildly unwell; slight headache/mild shooting pains into my left ear and on the left side of my head; mild shooting pains into my left ear and on the left side of my head for a couple of days; mild shooting pains into my left ear; This is a spontaneous report from a contactable nurse (patient). This non-pregnant 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EM-9809) via an unspecified route of administration in the left arm on 11Feb2021 at 14:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis, Hashimoto, nodular thyroid disease, and fever blister with the same shooting pain from unknown dates and unknown if ongoing. Prior to vaccination the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food or other products. Concomitant medications included metoprolol succinate and biotin from unknown dates for unknown indications. On 16Feb2021 at 08:00 the patient developed a moderately painful herpes simplex virus blister on her lower lip 5-6 days after the vaccine injection. She also felt mildly unwell with a slight headache and mild shooting pains into her left ear and on the left side of her head for a couple of days. The pains were reported as peripheral, not deep seated. She reported she had this fever blister before with the same shooting pains, but not after a vaccine. The events were reported as non-serious and did not require hospitalization. The patient was treated with valacyclovir (VALTREX) 2 grams every 12 hours for 2 doses on days 1 and 4. The clinical outcome of the moderately painful herpes simplex virus blister on her lower lip, felt mildly unwell, slight headache, and mild shooting pains into her left ear and on the left side of her head were reported as recovering. It was also reported that since vaccination the patient had not been tested for COVID-19.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: moderately painful herpes simplex virus blister on my lower lip; moderately painful herpes simplex virus blister on my lower lip; felt mildly unwell; slight headache/mild shooting pains into my left ear and on the left side of my head; mild shooting pains into my left ear and on the left side of my head for a couple of days; mild shooting pains into my left ear; This is a spontaneous report from a contactable nurse (patient). This non-pregnant 66-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EM-9809) via an unspecified route of administration in the left arm on 11Feb2021 at 14:30 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included osteoporosis, Hashimoto, nodular thyroid disease, and fever blister with the same shooting pain from unknown dates and unknown if ongoing. Prior to vaccination the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food or other products. Concomitant medications included metoprolol succinate and biotin from unknown dates for unknown indications. On 16Feb2021 at 08:00 the patient developed a moderately painful herpes simplex virus blister on her lower lip 5-6 days after the vaccine injection. She also felt mildly unwell with a slight headache and mild shooting pains into her left ear and on the left side of her head for a couple of days. The pains were reported as peripheral, not deep seated. She reported she had this fever blister before with the same shooting pains, but not after a vaccine. The events were reported as non-serious and did not require hospitalization. The patient was treated with valacyclovir (VALTREX) 2 grams every 12 hours for 2 doses on days 1 and 4. The clinical outcome of the moderately painful herpes simplex virus blister on her lower lip, felt mildly unwell, slight headache, and mild shooting pains into her left ear and on the left side of her head were reported as recovering. It was also reported that since vaccination the patient had not been tested for COVID-19.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Somnolence
Clinical narrative: sore muscles; sleepiness; This is a spontaneous report from a contactable consumer (patient). This 67-year-old male patient received dose 1 of BNT162B2 (PFIZER BIONTECH COVID-19 MRNA VACCINE) via an unspecified route of administration on 21Feb2021 at 09:00 (at the age of 67-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included COVID-19 prior to vaccination on an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. Concomitant medications were none. The patient did not have any allergies to medications, food, or other products. On 21Feb2021 at 21:30 the patient experienced sore muscles and sleepiness. The events were reported as non-serious. The patient was not hospitalized for the events. The patient did not receive any treatment for the events. The outcomes of sore muscles and sleepiness were not recovered. It was also reported that since the vaccine it was unknown if the patient had been tested for COVID-19.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Vaccination site pain
Clinical narrative: Significant soreness at injection site; Headache; tiredness; feeling as if in a bubble day of vaccine; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9266) via an unspecified route of administration in the right arm on 21Feb2021 at 13:45 (at the age of 26-years-old) as a single dose, for COVID-19 immunization. Medical history included asthma, weakened immune system, and allergy to loratadine (CLARITIN). Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included salbutamol (ALBUTEROL) as needed and fluticasone propionate/ salmeterol xinafoate (ADVAIR 500/50). On 21Feb2021 at 14:15, the patient experienced headache, tiredness and was feeling as if in a bubble the day of vaccine. The next day, on 22Feb2021, the patient experienced significant soreness at injection site. The patient was not treated for headache, tiredness, feeling as if in a bubble the day of vaccine, and significant soreness at injection site. The clinical outcome of headache, tiredness, feeling as if in a bubble the day of vaccine, and significant soreness at injection site was recovering.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Whole body hives; This is a spontaneous report from a contactable consumer (patient). This non-pregnant 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EL9266) via an unspecified route of administration in the left arm on 11Feb2021 at 16:45 (at the age of 73-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure (HBP), cholesterol, gout, penicillin allergy, and sulfa allergy, all from unknown dates and unknown if ongoing. Prior to vaccination the patient was not diagnosed with COVID-19. Concomitant medications were reported as "yes." The patient previously received oxytetracycline calcium (TERRAMYCIN) from an unknown date for an unknown indication and experienced allergy. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 12Feb2021 the patient experienced whole body hives, which were reported as still breaking out on "11Feb2021." The event was reported as non-serious and did not require hospitalization. The event resulted in a doctor or other healthcare professional office/clinic visit. The event was treated with prednisone, cetirizine hydrochloride (ZYRTEC), diphenhydramine hydrochloride (BENADRYL), and famotidine (PEPCID). The clinical outcome of the event was reported as recovering. It was also reported that since vaccination the patient had not been tested for COVID-19.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Left supraclavicular lymphadenopathy; This is a spontaneous report received from a contactable Other HCP (Patient). A 32-years-old (Non pregnant) female patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EL9266), via an unspecified route of administration on Left arm on 21Feb2021 09:45 (at age of 32-years-old) as single dose for COVID-19 immunization. The patient medical history was not reported and no Allergies to medications, food, or other products. The historical vaccine included first dose of BNT162B2 received on 25Jan2021 09:30 for COVID-19 immunization. The patients concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination, patient diagnosed with COVID-19. On 21Feb2021 13:00, patient experienced left supraclavicular lymphadenopathy. Since the vaccination, patient not tested for COVID-19. The outcome of the event was not recovered.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: migraine; This is a spontaneous report from a contactable consumer, the patient, reported for herself. A 41-years-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Batch/Lot Number: EN9261), via an unspecified route of administration in the left arm on 17Feb2021 16:15 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history was none. The patient had no allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to BNT162b2. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced migraine on 18Feb2021 at 15:00 and that lasted until Friday night on 19Feb2021. The patient did not receive treatment for event, migraine. The outcome of event, migraine was recovered on 19Feb2021.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dysstasia, Insomnia, Myalgia
Clinical narrative: so bad I couldn't sit or stand or anything; couldn't sleep; chills; muscle pain; joint pain; This is a spontaneous report from a contactable consumer (the patient). A female patient of an unspecified age received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot #: UNKNOWN), via an unspecified route of administration on 13Feb2021 as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that after the vaccination she had had all the reactions except 2. On 15Feb2021, the patient experienced couldn't sleep, chills, muscle pain, joint pain. She reported that on 16Feb2021 her symptoms were so bad that "I couldn't sit or stand or anything". Therapeutic measures were taken as a result of chills, muscle pain, joint pain, so bad i couldn't sit or stand or anything. She took Tylenol to treat her symptoms, and the next day they were resolved. The clinical outcome of the events chills, muscle pain, joint pain, so bad i couldn't sit or stand or anything was recovered. The clinical outcome of the remaining event was unknown.   Information about lot number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dyspnoea
Clinical narrative: back pain under left side of the ribs; hard to breathe; This is a spontaneous report from a contactable consumer, the patient. This 60 year old  female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown) single dose, dose 1, via an unspecified route of administration on 19Feb2021 for COVID-19 vaccination.  Medical history included back surgery. Concomitant medications were not reported. In Feb2021, the patient "started experiencing back pain under left side of the ribs, same side where she received the vaccine, hard to breathe" "not all the time, the first time happened when I was sleeping." The outcome of back pain and hard to breathe was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Severe bodyaches and sore injection site; Severe bodyaches and sore injection site; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant 43-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG201), via an unspecified route of administration in the left arm on 19Feb2021 at 14:45 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 prior to vaccination from an unknown date and unknown if ongoing. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included iron; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]); Vitamin D NOS; loratadine (CLARITIN); fluticasone propionate (FLONASE), all taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. The patient previously took codeine and experienced drug hypersensitivity. On 20Feb2021 at 06:00, the patient experienced severe body aches and sore injection site. The patient did not receive any treatment for the events. The clinical outcomes of the severe body aches and sore injection site were recovered with sequelae.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyskinesia, Feeling abnormal, Hypoaesthesia, Muscle twitching
Clinical narrative: dizzy; feeling drugged; numbness; loss of most use in hands; took extreme amount of planning and effort to speak a singular word or move any part of body; nausea; vomitting; Hands/ fingers, legs, eye, all developed tics; Legs were twitching all night; little achey; This is a spontaneous report from a contactable consumer (the patient). A non-pregnant 40-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot#: UNKNOWN), via an unspecified route of administration in the left arm on 06Feb2021 at 16:30 PM (at the age of 40 years) as a single dose for COVID-19 immunization. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications taken within two weeks of vaccination included bupropion hydrochloride (WELLBUTRIN), gabapentin, fluvoxamine. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took cephalexine and experienced drug hypersensitivity. On 06Feb2021 at 17:30 PM, the patient started to get dizzy, feeling "drugged", numbness, then loss of most use in hands (significant weakness- could not hold a cup), took extreme amount of planning and effort to speak a singular word or move any part of body, nausea, vomiting, hands/ fingers, legs, eye, all developed tics, legs were twitching all night, little achy. No treatment was taken for the events. The clinical outcome of the events was recovered. It was also reported that since the vaccination, the patient had  been tested for COVID-19 on 18Feb2021, Nasal Swab: Negative.  Information on the lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Muscular weakness, Nausea, Pain, SARS-CoV-2 test, Tic
Clinical narrative: dizzy; feeling drugged; numbness; loss of most use in hands; took extreme amount of planning and effort to speak a singular word or move any part of body; nausea; vomitting; Hands/ fingers, legs, eye, all developed tics; Legs were twitching all night; little achey; This is a spontaneous report from a contactable consumer (the patient). A non-pregnant 40-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot#: UNKNOWN), via an unspecified route of administration in the left arm on 06Feb2021 at 16:30 PM (at the age of 40 years) as a single dose for COVID-19 immunization. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications taken within two weeks of vaccination included bupropion hydrochloride (WELLBUTRIN), gabapentin, fluvoxamine. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took cephalexine and experienced drug hypersensitivity. On 06Feb2021 at 17:30 PM, the patient started to get dizzy, feeling "drugged", numbness, then loss of most use in hands (significant weakness- could not hold a cup), took extreme amount of planning and effort to speak a singular word or move any part of body, nausea, vomiting, hands/ fingers, legs, eye, all developed tics, legs were twitching all night, little achy. No treatment was taken for the events. The clinical outcome of the events was recovered. It was also reported that since the vaccination, the patient had  been tested for COVID-19 on 18Feb2021, Nasal Swab: Negative.  Information on the lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: dizzy; feeling drugged; numbness; loss of most use in hands; took extreme amount of planning and effort to speak a singular word or move any part of body; nausea; vomitting; Hands/ fingers, legs, eye, all developed tics; Legs were twitching all night; little achey; This is a spontaneous report from a contactable consumer (the patient). A non-pregnant 40-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot#: UNKNOWN), via an unspecified route of administration in the left arm on 06Feb2021 at 16:30 PM (at the age of 40 years) as a single dose for COVID-19 immunization. The patient medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19.  Concomitant medications taken within two weeks of vaccination included bupropion hydrochloride (WELLBUTRIN), gabapentin, fluvoxamine. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took cephalexine and experienced drug hypersensitivity. On 06Feb2021 at 17:30 PM, the patient started to get dizzy, feeling "drugged", numbness, then loss of most use in hands (significant weakness- could not hold a cup), took extreme amount of planning and effort to speak a singular word or move any part of body, nausea, vomiting, hands/ fingers, legs, eye, all developed tics, legs were twitching all night, little achy. No treatment was taken for the events. The clinical outcome of the events was recovered. It was also reported that since the vaccination, the patient had  been tested for COVID-19 on 18Feb2021, Nasal Swab: Negative.  Information on the lot/batch number has been requested.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Feeling abnormal, Head injury, Loss of consciousness
Clinical narrative: Patient fell from chair hitting head on ground after passing out. She responded to questions with appropriate answers within 45 seconds. She reported feeling dizzy and thought it was related to anxiety then woke up on the floor. Patient remained on the floor while being assessed by EMS then moved to a sitting position then to a chair when safe. Patient remained in chair for 10 minutes before leaving the vaccine site.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Fatigue, Feeling jittery
Clinical narrative: Chills, fever, dizziness, weakness, jittery, can?t sleep, fatigue, swollen, thirsty.  Received shot at 8:48am, symptoms began at 12:30pm while on a bike ride. I finished the ride but was too weak to do anything the rest of the day. That night I couldn?t stop shaking and lay in bed wide awake until about 2am. I felt dizzy like I was spinning when I closed my eyes.   I slept off and on until 6:30am. Today I?m feeling slightly better but still can?t sleep. I am drinking an excessive amount of water and herbal tea.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Pyrexia, Sleep disorder, Thirst
Clinical narrative: Chills, fever, dizziness, weakness, jittery, can?t sleep, fatigue, swollen, thirsty.  Received shot at 8:48am, symptoms began at 12:30pm while on a bike ride. I finished the ride but was too weak to do anything the rest of the day. That night I couldn?t stop shaking and lay in bed wide awake until about 2am. I felt dizzy like I was spinning when I closed my eyes.   I slept off and on until 6:30am. Today I?m feeling slightly better but still can?t sleep. I am drinking an excessive amount of water and herbal tea.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Dizziness
Clinical narrative: I have experienced light dizziness the first day (3/24) Today (3/25) I am unsure on my feet and have not been able to keep anything on my stomach. At first, I attributed this to a weight management plan that I am on, but late recalled the symptom described in my covid response reporting texts.  I Have yet to receive a Covid update text today, so I am submitting this report.  I am scheduled to see my PCP tomorrow.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Injection site pain, Pain, Pyrexia
Clinical narrative: Fever, chills, body aches, soreness at injection site
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Pain in extremity, Pyrexia
Clinical narrative: Fever, chills, body aches, soreness at injection site
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Neuropathy peripheral, Pain in extremity
Clinical narrative: The patient states that her neuropathy was "set on fire" after receiving the first dose of the Pfizer.  She said it was extremely bad and painful in her arms below her elbow.  She was barely able to use her hands.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: After 10 days after receiving the vaccine the PT had a rash show up as an oval shape at the injection site that lasted four days. It was red and itchy but the itchiness went away after two days.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Dizziness, Fatigue, Headache
Clinical narrative: Headache, fever, chills, nausea, dizziness, fatigue, achy joints
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Headache, fever, chills, nausea, dizziness, fatigue, achy joints
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: a sore arm "a little sore" at the injection site and tiredness "a little tired"  on the second day.; Covid-19 Vaccination, she experienced a sore arm "a little sore" at the injection site and tiredness "a little tired"  on the second day.; This is a spontaneous report from a contactable consumer, the patient.  A 80-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: Unknown), via an unspecified route of administration on 12Feb2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On Feb2021,  The patient experienced a sore arm "a little sore" at the injection site and tiredness "a little tired"  on the second day. The clinical course is as follows after her second Pfizer Covid-19 Vaccination, she experienced a sore arm "a little sore" at the injection site and tiredness "a little tired"  on the second day. Caller stated she received her second Pfizer Covid-19 Vaccine 12Feb2021. Patient  is scheduled for bone density test. Caller stated, 'they said I should wait 2 weeks prior to. It will be 11 days.' Caller asked will her bone density test have any effect on her vaccination. The clinical outcome of the events was unknown.      Information on the lot/batch number has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: 2 weeks after vaccine given left arm started to itch when checked are was red at injection sight with no noted swelling or fever.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives which responded to Benadryl
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Impaired work ability, Tinnitus
Clinical narrative: Tinnitus,, no benefits of home remedies, had to go on work leave.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Antinuclear antibody, Blood immunoglobulin G, Feeling abnormal, Full blood count
Clinical narrative: Tinnitus,, no benefits of home remedies, had to go on work leave.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, SARS-CoV-2 test, Tinnitus
Clinical narrative: Tinnitus,, no benefits of home remedies, had to go on work leave.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Pruritus, Swollen tongue, Tachycardia
Clinical narrative: the evening of the vaccine started having tongue swelling, difficulty breathing, itching, and tachycardia.  lasted 3 days
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Hypoaesthesia oral, Pharyngeal paraesthesia, Swelling, Throat tightness
Clinical narrative: Post COVID Vaccine injection  1639 numbness left lips, tingling in throat and feels tight BP 148/86 - HR 75 1643 Epi 0.3 via pen Right thigh Feeling shaking Medical emergency called  1645 Benadryl IM right arm. Feeling flushed  ED clinical staff here and transferred in own electric wh/chair. Husband with patient Allergy to CT Contrast - completely swollen shut
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Post COVID Vaccine injection  1639 numbness left lips, tingling in throat and feels tight BP 148/86 - HR 75 1643 Epi 0.3 via pen Right thigh Feeling shaking Medical emergency called  1645 Benadryl IM right arm. Feeling flushed  ED clinical staff here and transferred in own electric wh/chair. Husband with patient Allergy to CT Contrast - completely swollen shut
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Red egg shaped mark below injection site also a bump
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Testicular failure
Clinical narrative: 2/03/2021  Death.  No treatment.  Deceased.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic, Skin warm
Clinical narrative: The patient called 3/25/21 to report a rash on the right arm which began the day after the Moderna #2 vaccine on 3/22. The patient developed a rash on the right arm which is red, hot et itchy. Pt states, the rash is super itchy today (3/25). The nurse informed the patient to try Benadryl. If symptom is not better by morning, then visit with PCP for evaluation.   The patient verbally understood.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Hepatitis B immunisation, Inappropriate schedule of product administration
Clinical narrative: Client denied in written format and verbally that he received any other vaccinations 14 days prior to receiving the COVID vaccination.  Client had received Hep B (HEPLISAV-B) on 3/18/2021
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Nausea
Clinical narrative: Severe Abdominal Pain; nausea; This is a spontaneous report from a contactable consumer. A 53-years-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine), via an unspecified route of administration on 11Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization.The fa-cility type vaccine other was Drive thru.The patient had none Medical history. The patients Con-comitant medication included Allergy Medication and colecalciferol (VITAMIN D [COLECALCIFER-OL]) taken for an unspecified indication, start and stop date were not reported.The patient expe-rienced severe abdominal pain and nausea on 12Feb2021. No treatment was given to the patient.The outcome of the events was recovering.    Information about lot/batch number has been requested.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia
Clinical narrative: loss of smell and taste
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: VACCINE ERROR: DOSE GIVER OVER 6 HOURS AFTER VIAL PUNCTURED
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Taste disorder
Clinical narrative: Pt reported a bad taste in her mouth after receiving the 1st dose of COVID vaccine. She drank water and sx improved, but then returned. She then reported chest pressure, left side. She refused further eval in the local ED.
Age: 13.0
Sex: M
Vaccine: TDAP
Symptoms: Parosmia
Clinical narrative: A few days after the vaccine was given the patient developed disturbance in his smell.  He now states that everything smells "rotten".
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Swelling
Clinical narrative: Described by patient over phone - evaled in ER. Delayed arm redness/swelling. Resolving 1-2 weeks later.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site pruritus
Clinical narrative: Itchy injection site area 4? diameter irregularly shaped red skin at injection site area Slight pain at injection site area when pressed ?Hard? skin at injection site area
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: VACCINE ERROR: DOSE GIVEN OVER 6 HOURS AFTER VIAL PUNCTURED
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site swelling
Clinical narrative: Small, firm, red bump at injection site
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Blood magnesium, Blood pressure increased, Chest X-ray, Chest discomfort, Dyspnoea
Clinical narrative: Sudden onset of  feeling very hot overall. Had a concerning irregular bounding pulse with beats skipped after 3 beats and blood pressure elevated up to 178/80.  My chest had a buzzing or vibrating feeling. Felt a chest heaviness  and  and short of breath.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Extrasystoles, Feeling hot, Full blood count, Heart rate irregular
Clinical narrative: Sudden onset of  feeling very hot overall. Had a concerning irregular bounding pulse with beats skipped after 3 beats and blood pressure elevated up to 178/80.  My chest had a buzzing or vibrating feeling. Felt a chest heaviness  and  and short of breath.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Lipase, Metabolic function test, Prothrombin time, Troponin T, Troponin increased
Clinical narrative: Sudden onset of  feeling very hot overall. Had a concerning irregular bounding pulse with beats skipped after 3 beats and blood pressure elevated up to 178/80.  My chest had a buzzing or vibrating feeling. Felt a chest heaviness  and  and short of breath.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: No adverse event, but pt received a more potent dose. Pharmacist reconstituted with 0.8ml instead of 1.8ml.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Pain
Clinical narrative: My symptoms were terrible headache, wrist and ankle joint pain, muscle and body aches, and fatigue for 2 days
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Exercise tolerance decreased, Hypoaesthesia, Impaired work ability
Clinical narrative: Around 6 pm the same day of first pfizer vaccine (3/18/21), i woke up from a nap and my back hurt so bad that i couldn't leave the bed without falling out. My parents came and helped me out and gave me painkillers but really nothing helped. Next day, it started down my right arm (the arm NOT injected with the shot) and it started to hurt in my muscles everywhere and hasn't stopped to this day (3/25/21). Numbness and pins and needles feeling have occurred in my pinky and ring finger of right arm. Pain has now started in my knees as well after a few days from the shot. No pain killers work and I'm unable to write or type properly, or even work at my job frankly. I can't hold an object without it falling out of my hand, and when i am able to hold something, after about 2 seconds pain fills my arm. Nothing helps the pain. I saw my primary care physician on 3/25/21 and the PA said there wasn't anything to do for the intense pain i was having except take tylenol arthritis, melatonin (to help me sleep through the pain), exercise (even though it may cause me even worse pain), and a stress ball for my arm. I don't know what else to do with this pain and this was only the first round of shots.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Pain in extremity, Paraesthesia
Clinical narrative: Around 6 pm the same day of first pfizer vaccine (3/18/21), i woke up from a nap and my back hurt so bad that i couldn't leave the bed without falling out. My parents came and helped me out and gave me painkillers but really nothing helped. Next day, it started down my right arm (the arm NOT injected with the shot) and it started to hurt in my muscles everywhere and hasn't stopped to this day (3/25/21). Numbness and pins and needles feeling have occurred in my pinky and ring finger of right arm. Pain has now started in my knees as well after a few days from the shot. No pain killers work and I'm unable to write or type properly, or even work at my job frankly. I can't hold an object without it falling out of my hand, and when i am able to hold something, after about 2 seconds pain fills my arm. Nothing helps the pain. I saw my primary care physician on 3/25/21 and the PA said there wasn't anything to do for the intense pain i was having except take tylenol arthritis, melatonin (to help me sleep through the pain), exercise (even though it may cause me even worse pain), and a stress ball for my arm. I don't know what else to do with this pain and this was only the first round of shots.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Malaise, Pain, Pyrexia
Clinical narrative: FEELING UNDER THE WEATHER; Body aches; Chills; Fever; This is a spontaneous report from a contactable consumer (patient) and nurse, based on information received (manufacturer control number: EC-2020-083234). A male patient of unspecified age received the second dose of BNT162B2 (UNSPECIFIED TRADE NAME; lot number unknown) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation; and lenvatinib mesilate (LENVIMA 10 mg; lot number 1080976; expiration 30Aug2023) orally from 24Oct2020 at 10 mg daily for renal cell carcinoma. Medical history included pulmonary embolism, cardiac issues, and nephrectomy all from unknown dates and unknown if ongoing. Concomitant medications included vitamins, loperamide hydrochloride (IMODIUM), iron, and paracetamol (TYLENOL), all from unknown dates for unknown indications. The patient previously received codeine, lansoprazole, amoxicillin and clarithromycin, all from unknown dates for unknown indications and experienced drug allergies. The patient previously received the first dose of BNT162B2 (lot number unknown) on an unspecified date for COVID-19 immunisation. The patient reported feeling under the weather following the second COVID-19 shot, further reported as body aches, chills, and fever on unspecified dates. The action taken with lenvatinib mesilate was temporarily withdrawn on 18Feb2021 for 2 weeks. The clinical outcomes of the body aches, chills, fever, and feeling under the weather were not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Hypoaesthesia
Clinical narrative: Facial numbness - entire face.  Started about 30 minutes after injection.  It is better now (approximately 5 hours later) but it is still present. A bit hot feeling now.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination error
Clinical narrative: VACCINE ERROR: DOSE GIVEN OVER 6 HOURS AFTER VIAL PUNCTURED
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Patient received first dose of COVID-19 vaccine on 2/18/21 and received the Moderna COVID-19 vaccine. When patient came back for second dose on 3/25/21 patient was given Pfizer COVID-19 vaccine.
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: C-reactive protein, Catheterisation cardiac normal, Chest pain, Chills, Echocardiogram abnormal
Clinical narrative: Patient developed myalgias and chills the day after vaccination.  Three days after vaccination, awoke from sleep wtih burning upper chest and neck pain lasting several hours.  Came to the ED.  ECG notable for lateral ST elevation.  Troponin I elevated.  CRP elevated.  COVID PCR negative x2.  Treated with aspirin and intravenous heparin infusion.  Echocardiogram revealed left ventricular systolic dysfunction (EF 48%).  Cardiac catheterzation revealed no coronary obstruction or thrombosis.  Cardiac MRI revealed late gadolinium enhancement and myocardial edema consistent with acute myocarditis.  Max temperature during hospitalization 37.4C.